LifeMD LFMD Stock
LifeMD Price Chart
LifeMD LFMD Financial and Trading Overview
| LifeMD stock price | 4.55 USD |
| Previous Close | 4.75 USD |
| Open | 4.72 USD |
| Bid | 3.42 USD x 200 |
| Ask | 5.51 USD x 200 |
| Day's Range | 4.28 - 4.85 USD |
| 52 Week Range | 2.56 - 14.61 USD |
| Volume | 1.12M USD |
| Avg. Volume | 1.04M USD |
| Market Cap | 208.44M USD |
| Beta (5Y Monthly) | 1.985 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.44 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.88 USD |
LFMD Valuation Measures
| Enterprise Value | 180.14M USD |
| Trailing P/E | N/A |
| Forward P/E | 8.368932 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0781676 |
| Price/Book (mrq) | 13.639239 |
| Enterprise Value/Revenue | 0.932 |
| Enterprise Value/EBITDA | -12.599 |
Trading Information
LifeMD Stock Price History
| Beta (5Y Monthly) | 1.985 |
| 52-Week Change | -69.32% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 14.61 USD |
| 52 Week Low | 2.56 USD |
| 50-Day Moving Average | 4.54 USD |
| 200-Day Moving Average | 4.44 USD |
LFMD Share Statistics
| Avg. Volume (3 month) | 1.04M USD |
| Avg. Daily Volume (10-Days) | 956.92K USD |
| Shares Outstanding | 48.36M |
| Float | 40.08M |
| Short Ratio | 5.67 |
| % Held by Insiders | 14.46% |
| % Held by Institutions | 37.14% |
| Shares Short | 5.59M |
| Short % of Float | 13.81% |
| Short % of Shares Outstanding | 11.55% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 2.93% |
| Operating Margin (ttm) | -17.79% |
| Gross Margin | 86.80% |
| EBITDA Margin | -7.39% |
Management Effectiveness
| Return on Assets (ttm) | -13.40% |
| Return on Equity (ttm) | -238.45% |
Income Statement
| Revenue (ttm) | 193.33M USD |
| Revenue Per Share (ttm) | 4.19 USD |
| Quarterly Revenue Growth (yoy) | -1.40% |
| Gross Profit (ttm) | 167.83M USD |
| EBITDA | -14298176 USD |
| Net Income Avi to Common (ttm) | -21299564 USD |
| Diluted EPS (ttm) | -0.44 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 34.48M USD |
| Total Cash Per Share (mrq) | 0.71 USD |
| Total Debt (mrq) | 6.17M USD |
| Total Debt/Equity (mrq) | 41.05 USD |
| Current Ratio (mrq) | 1.043 |
| Book Value Per Share (mrq) | 0.316 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 8.1M USD |
| Levered Free Cash Flow (ttm) | -4156398 USD |
Profile of LifeMD
| Country | United States |
| State | NY |
| City | New York |
| Address | 236 Fifth Avenue |
| ZIP | 10001 |
| Phone | 866 351 5907 |
| Website | https://lifemd.com |
| Industry | Health Information Services |
| Sector(s) | Healthcare |
| Full Time Employees | 347 |
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Q&A For LifeMD Stock
What is a current LFMD stock price?
LifeMD LFMD stock price today per share is 4.55 USD.
How to purchase LifeMD stock?
You can buy LFMD shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for LifeMD?
The stock symbol or ticker of LifeMD is LFMD.
Which industry does the LifeMD company belong to?
The LifeMD industry is Health Information Services.
How many shares does LifeMD have in circulation?
The max supply of LifeMD shares is 48.36M.
What is LifeMD Price to Earnings Ratio (PE Ratio)?
LifeMD PE Ratio is now.
What was LifeMD earnings per share over the trailing 12 months (TTM)?
LifeMD EPS is -0.44 USD over the trailing 12 months.
Which sector does the LifeMD company belong to?
The LifeMD sector is Healthcare.
LifeMD LFMD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
US Tech Global Market Composite
NQGM
US
|
2310.38 USD — |
-1.07
|
— — | 2287.99 USD — | 2333.46 USD — | — - | — — |
- {{ link.label }} {{link}}


